5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE
5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE
Discontinued
DIN Number
02142252
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
baxter corporation clintec nutrition division
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02142252
AIG Number1650849010
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA10 COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification
ACTIVE INGREDIENTS (16)
DEXTROSEActive
Strength: 20 G / 100 ML
Monograph: DEXTROSE
GLYCINEActive
Strength: 515 MG / 100 ML
Monograph: GLYCINE
HISTIDINEActive
Strength: 240 MG / 100 ML
Monograph: HISTIDINE
L-ALANINEActive
Strength: 1.04 G / 100 ML
Monograph: L-ALANINE
L-ARGININEActive
Strength: 575 MG / 100 ML
Monograph: L-ARGININE
L-ISOLEUCINEActive
Strength: 300 MG / 100 ML
Monograph: L-ISOLEUCINE
L-LEUCINEActive
Strength: 365 MG / 100 ML
Monograph: L-LEUCINE
L-PHENYLALANINEActive
Strength: 280 MG / 100 ML
Monograph: L-PHENYLALANINE
L-PROLINEActive
Strength: 340 MG / 100 ML
Monograph: L-PROLINE
L-THREONINEActive
Strength: 210 MG / 100 ML
Monograph: L-THREONINE
L-TYROSINEActive
Strength: 20 MG / 100 ML
Monograph: L-TYROSINE
L-VALINEActive
Strength: 290 MG / 100 ML
Monograph: L-VALINE
LYSINE (L-LYSINE HYDROCHLORIDE)Active
Strength: 290 MG / 100 ML
Monograph: LYSINE (L-LYSINE HYDROCHLORIDE)
METHIONINEActive
Strength: 200 MG / 100 ML
Monograph: METHIONINE
SERINEActive
Strength: 250 MG / 100 ML
Monograph: SERINE
TRYPTOPHANActive
Strength: 90 MG / 100 ML
Monograph: TRYPTOPHAN